Please login to the form below

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

AbbVie/Allergan merger faces renewed public opposition despite divestments

AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and ... This in turn could

Latest news

Ex-Sandoz exec admits role in generic drug price-fixing plot

Reignites criticism of high drug prices in the US. Former Sandoz executive Hector Armando Kellum has pled guilty to charges levied against him, which allege he participated in a price-fixing ... President Donald Trump, as well as Democratic presidential
US start-up EQRx promises approach that will slash drug prices

Plans to have its first drug on the market in just five years. ... A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost.
AbbVie creates new aesthetics division amid Allergan takeover

It will be led by Allergan’s current senior vice president, US medical aesthetics Carrie Strom, who will go on to assume the new roles of senior vice president of AbbVie ... areas, and also could cause high drug prices in the US to continue or worsen.
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
Biologic patent exclusivity scrapped in new US trade deal

President Trump has made drug pricing a key target for his administration, and both his Republican party and the opposition Democrat party are focusing on high drug prices as a major ... The Democrats also launched their own plans to tackle high drug

More from news
Approximately 12 fully matching, plus 28 partially matching documents found.

Latest Intelligence

BRIC markets

US drug prices are often used as a direct or indirect reference for products sold in BRIC markets. ... As a result US government efforts to reduce pharmaceutical prices is likely to have an impact.”.
Will biosimilars ever catch on in the US?

exclusivity ends. Thus in the US we see generic drug prices often reduced by as much as 90% or more, with uptake then rising accordingly. ... As prices in the US continue to spiral out of control, we can only look on with envy.
The Golden Goose

Why it’s so hard for the US to curb runaway drug prices. ... Something that is seldom mentioned in the drug pricing debate: the US has a greater number of generics sold at cheaper prices than any other country in the world, with 90%
The Orkambi blame game

The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive
Deal Watch October 2018

US drug prices. In other news from the US, there are now expectations of a legislative stalemate following the mid‐term elections in early November. ... It is worth remembering that there are still a few areas where both political parties are prepared

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....